Notice of Privacy Incident
Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: March 19, 2014 (revised April 7, 2014)

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Sovaldi	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Otrexup	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Brintellix	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Olysio	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Natroba	New Drug Appeal	Require Prior Approval	Prior Approval Required
Quillivant XR	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Linzess	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
TOBI Podhaler	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Abilify Maintena	PDL Appeal	Add to Preferred Status	Preferred and Require Prior Approval
Onglyza	PDL Appeal	Require Prior Approval	Prior Approval Required

Footer